Back to the Top 100
Pulmonx logo

Rank 77MedTech & Devices

Pulmonx

Manufactures minimally invasive medical devices for treating severe emphysema, including the Zephyr Endobronchial Valve.

Visit website
Signal Score
82.8
Total raised
$200M
Stage
Public
Founded
1995
Headquarters
Redwood City, USA
Region
North America

Their signal

Dominates the interventional pulmonology sector with robust clinical trial data, establishing a highly effective mechanical treatment alternative for patients with severe COPD.

Signal Score 82.8editorial estimate, see how it is built
Capital (25% weight)80

Total raised, quality of investors and recency of the last round.

Growth (25% weight)82

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)90

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)85

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)77

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in MedTech & Devices

ShareLink copied

Did we miss something?

Change, add or remove details on this company. Our desk reviews every request.

Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.